Red Spruce Capital
MRK icon

Red Spruce Capital’s Merck MRK Stock Holding History

Red Spruce Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.84M Sell
26,416
-24
-0.1% -$3.32K 1.36% 22
2026
Q2 		$3.4M Buy
26,440
+347
+1% +$40.6K 1.18% 27
2026
Q1 		$3.14M Buy
26,093
+348
+1% +$40.2K 1.29% 28
2025
Q4 		$2.71M Buy
25,745
+651
+3% +$61.1K 1.08% 32
2025
Q3 		$2.11M Sell
25,094
-16,425
-40% -$1.35M 0.86% 42
2025
Q2 		$3.29M Sell
41,519
-808
-2% -$64.2K 1.42% 24
2025
Q1 		$3.8M Sell
42,327
-412
-1% -$38.5K 1.79% 16
2024
Q4 		$4.25M Buy
42,739
+3,299
+8% +$340K 1.89% 14
2024
Q3 		$4.48M Sell
39,440
-159
-0.4% -$18.9K 2.04% 14
2024
Q2 		$4.9M Buy
39,599
+438
+1% +$56.4K 2.28% 12
2024
Q1 		$5.17M Buy
39,161
+139
+0.4% +$17.1K 2.4% 11
2023
Q4 		$4.25M Buy
39,022
+621
+2% +$64.5K 2.18% 13
2023
Q3 		$3.95M Buy
38,401
+16
+0% +$1.72K 2.24% 11
2023
Q2 		$4.43M Sell
38,385
-13,875
-27% -$1.58M 2.39% 11
2023
Q1 		$5.56M Buy
52,260
+847
+2% +$91.4K 3.25% 6
2022
Q4 		$5.7M Buy
51,413
+832
+2% +$85K 3.63% 5
2022
Q3 		$4.36M Sell
50,581
-2,816
-5% -$251K 3.06% 7
2022
Q2 		$4.87M Sell
53,397
-381
-0.7% -$33.8K 3.24% 6
2022
Q1 		$4.41M Buy
53,778
+1,991
+4% +$157K 2.5% 9
2021
Q4 		$3.97M Buy
51,787
+2,395
+5% +$191K 2.17% 10
2021
Q3 		$3.71M Buy
49,392
+3,671
+8% +$279K 2.17% 11
2021
Q2 		$3.56M Sell
45,721
-248
-0.5% -$18.4K 2.1% 12
2021
Q1 		$3.38M Buy
45,969
+4,771
+12% +$352K 2.15% 11
2020
Q4 		$3.22M Buy
41,198
+754
+2% +$57.7K 2.23% 11
2020
Q3 		$3.2M Sell
40,444
-144
-0.4% -$11.3K 2.6% 9
2020
Q2 		$3M Buy
40,588
+22,131
+120% +$1.67M 2.54% 10
2020
Q1 		$1.36M Buy
18,457
+293
+2% +$23K 1.41% 27
2019
Q4 		$1.58M Buy
+18,164
New +$1.49M 1.31% 31

Other funds holding MRK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Red Spruce Capital's MRK Position: Q3 2026 in Review

Red Spruce Capital reduced its Merck (MRK) stake by 0.09% in Q3 2026, selling an estimated $3.32K and leaving 26,416 shares worth $3.84M. The position accounts for 1.36% of the portfolio, ranked #22.

Red Spruce Capital first reported a position in MRK in Q4 2019 and has held it in 28 quarters since. The position peaked at $5.7M in Q4 2022. 2,693 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Red Spruce Capital held 26,416 shares of Merck worth $3.84M as of Q3 2026.
  • Red Spruce Capital sold 24 Merck shares in Q3 2026, an estimated $3.32K.
  • Merck made up 1.36% of Red Spruce Capital's portfolio in Q3 2026, its #22 holding.
  • Red Spruce Capital first reported a position in Merck in Q4 2019 and has held it in 28 quarters since.
  • Red Spruce Capital's Merck position peaked at $5.7M in Q4 2022.
  • 2,693 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Red Spruce Capital's 13F filing for Q3 2026, filed 7 Oct 2026.